Key facts
- Notable investors include Red Cedar Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for CytoHub
- ·The full record, as it builds
Funding rounds
No funding rounds for CytoHub are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CytoHub
Developer of a cell biology research and development platform designed to support discovery and preclinical programs. The company's platform integrates induced pluripotent stem cell technologies, organoid and cell-based assay development, and AI-driven bioengineering workflows, enabling biopharmaceutical and academic research organizations to conduct translational and therapeutic research.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2023
- Employees
- 10
- Website
- cytohub.com/
- Ownership
- Privately Held (backing)
CytoHub doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CytoHub shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CytoHub in its N-PORT filings yet. We sweep new filings monthly.